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The aim of this prospective study (20 months) was to assess HIV patients’ use of Traditional, Complementary and 
Alternative Medicine (TCAM) and its effect on ARV adherence at three public hospitals in KwaZulu-Natal, South Africa. Seven  
hundred and thirty-five  (29.8% male and 70.2% female) patients who consecutively attended three HIV clinics completed 
assessments prior to ARV initiation, 519 after 6 months, 557 after 12 and 499 after 20 months on antiretroviral therapy (ART). 
Results indicate that following initiation of ARV therapy the use of herbal therapies for HIV declined significantly from 36.6% 
prior to ARV therapy to 8.0% after 6 months, 4.1% after 12 months and 0.6% after 20 months on ARVs. Faith healing methods 
(including spiritual practices and prayer) declined from 35.8% to 22.1%, 20.8% and 15.5%, respectively.  In contrast, the use of 
micronutrients (vitamins, etc.) significantly increased from 42.6% to 78.2%. The major herbal remedies that were used prior to 
ART were unnamed traditional medicine, followed by imbiza (Scilla natalensis planch), canova (immune booster), izifozonke 
(essential vitamins mixed with herbs), African potato (Hypoxis hemerocallidea), stametta (aloe mixed with vitamins and herbs) 
and ingwe (tonic). Herbal remedies were mainly used for pain relief, as immune booster and for stopping diarrhea. As herbal 
treatment for HIV was associated with reduced ARV adherence, patient’s use of TCAM should be considered in ARV adherence 
management. 
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Traditional, complementary and alternative medicine (TCAM)  broadly comprises herbal remedies, spiritual practices 
and prayer, traditional Chinese medicines, acupuncture, acupressure, chiropractic care, massage therapy,  meditation, 
visualization, therapeutic touch and micronutrients (vitamins, minerals, and multivitamins). TCAM has been demonstrated to be 
widely used by people living with HIV (PLHIV), both on and off ARV therapy, as primary treatment for HIV/AIDS and for HIV-
related problems (e.g., Babb et al., 2007; Josephs et al., 2007; Langlois-Klassen et al., 2007; Ma et al., 2008; Malangu, 2007; 
Mills et al., 2005; Peltzer et al., 2008, 2010; Reid et al., 2008). Numerous medicinal plants used by traditional medicine 
practitioners for the treatment of HIV/AIDS and related conditions in sub-Saharan Africa have been identified (Klos et al., 2009; 
Lamorde et al., 2010; Theo et al., 2009) including Hypoxis hemerocallidea (African potato) and Sutherlandia (Mills et al., 2005a) 
and micronutrient interventions (Friis, 2006) which could be used as potential therapy for HIV. 
There is data to suggest that TCAM impacts on ARV adherence, although the findings are variable and findings are 
inconsistent across studies (Littlewood and Vanable, 2008; Owen-Smith et al., 2007; Peltzer et al., 2010).  
There seem to be no longer-term prospective studies on the use of TCAM and its impact on antiretroviral treatment (ART) 
adherence in Africa. Therefore, the aim of this longer-term prospective study was to assess HIV patients’ use of TCAM and its 
effect on ARV adherence over a 20 months period at three public hospitals in KwaZulu-Natal, South Africa. Previous studies 
(with the same sample) had assessed only global categories of traditional, complementary and alternative medicine for HIV at 
baseline and six months follow-up (Peltzer et al., 2008; Peltzer et al., 2010), while this report describes the details of each 
traditional, complementary and alternative medicine used and reasons of its use over 4 time points (including 12 and 20 months 
follow-up) and ART adherence at 12 and 20 months follow-up. 
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This was a prospective study of all adult treatment-naϊve patients (N = 735) recruited from the three public hospitals in 
Uthukela health district in KwaZulu-Natal, South Africa  from October 2007 to February 2008. All ARV-naϊve patients who were 
about to start ARVs (18 years and above) and who consecutively attended the HIV clinics during the recruitment period were 
eligible for this study. Details of the setting, sampling procedure and recruitment have been described elsewhere (Peltzer et al., 
2008). Patients were interviewed at  6, 12 and 20 months clinic visits post initiation of ARV follow-up. Patients who failed to 
attend the planned follow-up were contacted by telephone and up to two home visits before being considered lost to follow-up.  
Ethics approval was obtained from the Human Sciences Research Council (HSRC) ethics committee. Permission to conduct the 





Patients were interviewed using an anonymous questionnaire administered by the research team. Information was 
collected on socio-demographic characteristics, clinical history and health-related characteristics, TCAM use and health beliefs. 
Following initiation of ARVs, information on side effects, and changing or interrupting ART was also obtained. The use of 
TCAM was assessed with questions on 8 different TCAM methods over the past six months, the duration of usage, costs and the 
awareness of the health care provider of using TCAM. Further, participants were asked for what reasons that had used each 
specific TCAM method. The response options included (a) To treat adverse effects from ARV treatment (e.g. nausea/vomiting), 
(b) Relaxation, (c) Pain relief, (d) Stress relief, (e) Immune supplementation, (f) Antioxidant, (g) Improve eating, (h) improve 
overall well-being, (i) Anxiety, (j) Depression, (k) Fatigue, (l) Neuropathy, (m) Diarrhoea, and (i) Other (specify). Clinical data 
relating to date of HIV diagnosis, HIV acquisition and transmission risk factors, current CD4 cell count, viral load (Chiron 3.0 
bDNA), opportunistic infections, HIV and non-HIV medications was obtained from the medical chart.  
 
Adherence assessment  
 
The 30-day visual analog scale (VAS) provided an overall adherence assessment for a longer time interval. The VAS is 
a valid method of assessing medication adherence (Kalichman et al., 2009) and has been validated in resource-limited settings 
(e.g. Maneesriwongul et al., 2006).  Adherence was calculated as the % of doses taken over those prescribed. Adherence levels 
assessed from the VAS are defined as follows: full adherence = 100%, partial adherence >/= 95% and < 100%, and non-adherence 




Scientific names of herbal and other indigenous remedies were as far as possible identified using “HEALTHLIT”, a 
database including a Dictionary of South African Traditional Medicinal Plants and Zulu Medicinal Plants (Hutchings et al., 1996). 
Data were analyzed using Statistical Package for the Social Sciences (SPSS) for Windows software application programme 
version 17.0. Frequencies, means, standard deviations, median and interquartile ranges were calculated to describe the sample. 
Bivariate analyses using logistic regression were conducted to examine the relationships between overall TCAM use, herbal 
remedy use and socio-demographic variables, health characteristics, ART adherence and further health-seeking behaviour 
variables. Multivariate logistic regression included in the model all variables statistically significant at the 5% level in bivariate 
analyses. No significant interactions were found between socio-demographic variables health-seeking behaviour and health 
characteristics. In multivariate regressions for ART adherence, adjustment was made for site of care, to account for variations in 







A total of 735 patients (217 men and 518 women) completed a baseline questionnaire at Time 1 prior to initiating ART. Follow-
up questionnaires were completed at 6 months follow-up by 519 patients within this cohort (139 men and 370 women) who had 
now been on ART for six months, at 12 months later by 557 patients within this cohort (157 men and 396 women), and 20 months 
later by 499 patients (126 men and 333 women); 122 (16.9%) participants were lost-to-follow-up (including transfers), and 83 
(11.5%) were known to have died, of whom, 75 had already died at six months follow-up, 72 transferred care elsewhere, 14 
refused participation, 12 were not initiated on ART and 50 (6.9%) could not be traced.  At time 4, HIV medications for 380 
(76.3%) patients included Lamivudine (3TC), Stavudine (d4T) + Efavirenz and for 118 (23.7%) Lamivudine (3TC), Stavudine 
(d4T) + Nevirapine. 
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The mean age of the participants at baseline assessment was 35.9 years, std deviation= 9.7 years, the educational level  
Table 1: Sample characteristics of patients at baseline assessment 
Variable N=735 % 
Sex 
   Male 







Age, range 18-67 35.9 9.7 
Age, less than 36 417 56.7 
Education 
   Grade 7 or less 
   Grade 8-11 
   Grade 12 or more 












   Traditional African religion or none 
   Main stream Christian 
   Charismatic 












   Rural (village) 
   Rural (farm) 
   Urban (informal settlements) 
   Urban (formal settlements) 














   Housewife/houseman 
   Unemployed 
   Employed 
   Pensioner/disabled/student 
   Other 
















   Formal salary 
   Family member contributions 
   Social grants 
    
      No income 
   Other 

















Time since HIV diagnosis 
  ≤1 year (2007/8) 
   1-2 years (2006) 









CD4 count (cells/uL)= T4: Median=446 (IQR=305-618), T3: Median=261 
(IQR=176-387), T2=130 (IQR=72-185) (at baseline: 119; IQR=59-163)  
   1-99 
   100-349 













of the majority (81.0%) was less than Grade 12. Almost three quarters (71.8%) were never married, 61.2% were unemployed and 
20.2% employed, more than half  (52.3%) had a child care grant, 29.9% had a formal salary and 7.9% had no income. Almost 
two-thirds (63.3%) resided in a rural area, most (73.5%) had been recently (within the past year) diagnosed as being HIV positive 
and almost all (96.1%) had disclosed their HIV status to someone. While baseline characteristics were similar between men and 
women, women were more likely to be younger and receiving social (including child care) grants, and men were more likely to be 
married or cohabitating, employed and having a formal salary. The median CD4 count at 20 months follow-up was 446 
cells/cu.mm compared to 261 cells/cu.mm at 12 months follow-up, 130 cells/cu.mm at 6 months follow-up and compared to 119 
cells/cu.mm prior to ARV initiation (see Table 1). 
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Table 2: Frequency distribution of the use, costs, awareness of the care provider of different TCAM (Traditional, 
complementary and alternative medicine) for HIV in the past six months (prior to ART=Time 1(T1), N=735; follow-
up one (T2), N=525); follow-up two (T3) (n=556); and follow-up three (T4) (n=499) 








  N % M (SD)  M (SD)  n (%) 
1. Herbal therapies (e.g., Ginseng, 
Echinacea or St. John’s Wort, Hypoxis 

























2. Faith healing including spiritual 











































































































Following initiation of ARV therapy the use of herbal therapies for HIV declined significantly from 36.6% prior to ARV therapy 
to 8.0% after 6 months, 4.1% after 12 months and 0.6% after 20 months on ARVs. Faith healing methods (including spiritual 
practices and prayer) declined from 35.8% to 22.1%, 20.8% and 15.5% respectively, and physical/body-mind therapy (exercise 
and massage) declined from 5.0% to 1.9%, 0.5% and 0.6%.  In contrast, the use of micronutrients (vitamins, etc.) significantly 
increased from 42.6% to 93.8% at 12 months but then decreased to 78.2% at 20 months. At baseline only 10.2% of patients 
reported that their health care provider was aware of their herbal remedy use. This figure declined to 4.7% after 6 months, 4.2% 
after 12 months and 0% after 20 months on ARVs. Patients were more willing to disclose faith healing methods than herbal 
remedies to their health care provider, with the disclosure rate increasing from 16.1% at baseline to 35.1% at 20 months follow-up 
(see Table 2).  
 
The major herbal remedies that were used prior to ART were unnamed traditional medicine (57), followed by imbiza (43), canova 
(31), izifozonke (21), African potato (15), stametta (14) and ingwe (10). The use of African potato (9), canova (8) and izifozonke 
(7) proportionally continued to time 2 (6 months on ART), while the use of stametta (1) and ingwe (2) drastically reduced. Herbal 
remedy use at time 3 (12 months on ART) was mainly stametta (5), canova (3) and Tre-en-en (4), while African potato, imbiza, 
ingwe, izifozonke were no longer used, and at 20 months follow-up the use of herbal remedies had virtually stopped. Participants 
reported the use of herbal remedies for a number of purposes, mainly pain relief, immune booster and stopping diarrhea. Over 
time it appears the use of herbal remedies for pain relief reduced (African potato, ingwe, izifozonke). Herbal remedies were often 
obtained over-the-counter (e.g. canova, stametta, ingwe), some from both the traditional healer and over-the-counter (e.g. African 
potato, izifonzonke) and from the traditional health practitioner only (e.g. unnamed traditional medicine) (see Table 3).    
Overall, herbal therapies were believed to be used at 6.1% at time 1 to treat adverse effects of HIV, and at time 2 and 3 
(4.3% and 3.3% respectively) for treating adverse effects from ARV treatment. Over time herbal remedies were used at time 1 for 
pain relief (27.9%), to improve eating (14.7%), improve overall well-being (13.2%), as an antioxidant (9.9%) and for stress relief 
(17.3%). At time 2 and 3 herbal remedies were used for immune supplementation (65% and 70%). Faith healing was primarily 
used to improve overall well-being and stress relief, similarly over time. Physical/body-mind therapy was mainly used for stress 
relief and relaxation, and micronutrients for immune supplementation and improving the overall well being. Finally, over-the-
doi: 10.4314/ajtcam.v8i4.1
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counter drugs were mainly used for pain relief. The belief that TCAM can be solely used to treat HIV was shared by 6.1% prior to 
ART, 1.5% at 6 months and 4.8% at 12 months on ART (see Table 4). 
 







































































Herbal remedy        
African potato / Zambane/ [Hypoxis 
hemerocallidea] 
15 9   X X Immune booster, pain relief 
Aloestra Aloe extra, Inhlaba [Aloe Ferox] 4 1    X Immune booster, stress relief 
Berocca  1 1   X Immune booster 
Canova 
31 8 3   X Immune booster, pain relief , stress 
relief, antioxidant, improve eating 
Dubulageqe  
6    X X Pain relief, stress relief, body 
cleansing 
Ichitha [Scilla natalensis] 5     X Pain relief, Immune booster 
Ikhambi  [Eclipta prostrata] [ plants are used for 
skin infections] 
2    X  Pain relief, Immune booster 
Imbiza yomzimba; Inguduza [Scilla natalensis 
Planch] 
[plant extracts show antimicrobial activity against 
pus-forming organisms; causes haemolysis when 
applied to blood agar; extracts possess antiseptic, 
anti-inflammatory and healing properties] 
44    X  Pain relief, Relaxation, stress relief, 
Immune booster, antioxidant, improve 
eating, improve overall wellbeing 
Ingwe makoya tonic   
10 2    X Pain relief, Immune booster, improve 
overall well-being, relaxation, stress 
relief, improve overall wellbeing 
Ingungumbane  2    X Immune booster  
Insimbi 
3     X Pain relief, stress relief, Immune 
booster 
Isibabuli 1    X  Pain relief 
Isicoco 1    X  Immune booster 
Izifozonke [a formulated mixture of essential 
vitamins & nutrients blended with quality African 
Herbs and roots] 
21 7   X X Pain relief, relaxation, stress relief, 
Immune booster, diarrhea, depression 
Khotha  1 1  X  Relaxation, pain relief 
Madudula 1     X Pain relief 
Magogotha  1    X Aphrodisiac 
Mahlokoza 1      Immune booster 
Ncinda 1  1  X  Relaxation, Immune booster 
Red muti 
9 2    X Pain relief, Relaxation, Immune 
booster , stress relief, improve eating 
Stametta [product containing aloe in combination 
with vitamins, minerals, herbal extracts] 
14 1 5   X Immune booster, relaxation, pain 
relief, diarrhea, stress relief, 
antioxidant, improve eating, improve 
overall wellbeing 
Tre-en-en [phytonutrient supplement including 
omega-6 and omega-3 fatty acids, and phyto-
STEROLS, including beta-sitosterol, gamma-
oryzanol, stimasterol, and campesterol, plus 
octacosanol] 
  4  X X Pain relief; Immune booster  
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5 2   X  Immune booster, diarrhea, pain relief, 
side effects from ART, stress relief, 
antioxidant, improve eating 
Ukuchata 1     X Pain relief 
Umagadla esheshisa 2 1 2   X Immune booster , pain relief 
Umphumputho [Cephalaria attenuata] [not 
specified Chemical constituents: not specified 
Biological properties: not specified] 
1     X Diarrhea 
Umtholo obomvo [Acacia caffra] 1    X  Pain relief 
Umuthi omhlophe 1    X  Diarrhea, body cleansing 
Vukuhlale/Vukwabafile [Myrothamnus 
flabellifolius] 
18  10 3 X X Pain relief, side effects from ART, 
stress relief, antioxidant, improve 
eating, relaxation 
Herbal remedy (unnamed)        
Traditional medicine, bottle 
57 3   X  Pain relief, Immune booster , side 
effects from ART, diarrhea, 
relaxation, stress relief, antioxidant, 
improve eating, improve overall 
wellbeing 
Other remedies        
Energy booster, immunizer Insimbi, cell food 
[Energy booster] Isibabuli [Immune booster] 
Ncengimpilo[Immune booster] extra power 
2 2 6   X Immune booster, side effects from 
ART 
Epsom salt, Bio-oil, Philani fortified cereal given 
free to those who are HIV positive and on ARVs 
1 2    X Relaxation, diarrhea,  




























To treat adverse 





























































































































Improve eating T1=108 (14.7) T1=92 (12.5) T1=8 (1.1) T1=112 (15.2) T1=# 
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Table 5: Association between TCAM use, socio-demographic variables, CD4 cell count and antiretroviral adherence (>95%) at 
time 3 (12 months follow-up) and time 4 (20 months follow-up) 






























Grade 7 or less 
Grade 8-11 

















African or none 














































































Herbal treatment 0.08 (0.04-0.15)*** 0.18 (0.07-0.50)*** 0.04 (0.00-0.50)* 0.11 (0.01-1.55) 





















Significant at *P <.05, **P<.01, ***P<.001 
a Hosmer and Lemeshow Chi-square 10.97, p.20; Cox & Snell R2 .13; Nagelkerke R2 .27 
b Hosmer and Lemeshow Chi-square 5.39, p.72; Cox & Snell R2 .08; Nagelkerke R2 .19 
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At 12 and 20 months using the VAS 89.6% and 91.6%, respectively, reported ART adherence at ≥95%. Bivariate 
analyses for ART adherence at time 3 (12 months follow-up) found that belonging to traditional African or no religion, urban 
residence, being a housemaker, having a formal salary, higher CD4 count, the non-use of herbs and faith healing were associated 
with ART adherence at 12 months, while in multivariate analysis urban residence (OR: 3.7, 1.6-8.8), being employed (OR: 6.5, 
1.2-34.4) or unemployed (OR: 5.9, 1.4-25.7), belonging to a main stream Christian church (OR: 2.3, 1.0-5.3) and non-use of herbs 
(OR: 0.2, 0.1-0.5) were retained. Further, bivariate analyses for ART adherence at time 4 (20 months follow-up) found that 
belonging to a main stream Christian church, being unemployed, no formal salary income, non-use of herbs, faith healing and 
higher CD4 count were associated with ART adherence at 20 months, while in multivariate analysis higher CD4 counts (OR: 4.7, 





In this prospective study following initiation of ARV therapy the use of herbal therapies and faith healing methods 
(including spiritual practices and prayer) for HIV declined significantly from prior to ARV therapy to after 6, 12 and 20 months 
on ARVs, and the use of micronutrients (vitamins, etc.) significantly increased over time. Both herbal and faith healing declined 
with longer time on ART, which may indicate the effectiveness of ART. The use of micronutrients increased mainly because they 
were provided in the medical setting. 
The study found that major herbal remedies that were used for HIV were unnamed traditional medicine, imbiza, canova, 
izifozonke, African potato, stametta, ingwe, vukuhlale and aloe. Similarly, Babb et al. (2007) found in a workplace ART clinic in 
South Africa of 14 patients receiving ART and concomitantly using traditional medicines, it was reported that a total of 22 
products, most frequently African potato and Aloe vera were used. In this study patients had used the African potato but later 
stopped it. Sutherlandia was not used although it is commonly used in other populations. Mills et al. (2005b) examined the effects 
of two African herbal medicines recommended for HIV/AIDS patients on antiretroviral metabolism. Extracts from Hypoxis and 
Sutherlandia showed significant effects on cytochrome P450 3A4 metabolism and activated the pregnane X receptor 
approximately twofold. P-glycoprotein expression was inhibited, with Hypoxis showing 42-51% and Sutherlandia showing 19-
31% of activity compared with verapamil. Initiating policies to provide herbal medicines with antiretroviral agents may put 
patients at risk of treatment failure, viral resistance or drug toxicity. Yet Brown et al. (2008) found that Hypoxis hemerocallidea 
and l-canavanine interact with the efflux of nevirapine across intestinal epithelial cells and therefore can potentially increase the 
bioavailability of this antiretroviral drug when taken concomitantly. Thus far, biomedical evidence has revealed that African 
potato  extracts possess anti-inflammatory, antineoplastic, antioxidant, antidiabetic and antiinfective properties in vivo and in 
vitro. But more laboratory and clinical studies are required to clarify these observations, and to isolate, purify and characterize the 
active chemical constituents responsible for the herb's pharmaco-therapeutic effects (Owira and Ojewole, 2008).  Canova was 
widely used in this study, it is a homeopathic product, produced according to the Hahnemannian homeopathic method, and seems 
to stabilize platelet morphology in HIV/AIDS (Smit et al., 2009). There is a need to provide information of the safety and efficacy 
of different TCAM methods. 
The study found that most health care providers were not aware of the use of herbal treatment of their patients, as 
reported by the patients in this study, this even decreased over time. Reasons for this could be the explicit training patients receive 
on being discouraged to use herbal treatments and because of social desirability. On the other hand health care providers became 
more aware over time on the use of faith healing and over-the-counter drugs of their patients. Interventions targeted towards both 
health care provider and patients many enhance communication of TCAM use, avoid potential adverse events and drug 




One limitation of this study is the self-report data for both TCAM use and HAART adherence. In addition, only patients 
and not health workers were interviewed, which could have provided their perspective on TCAM use among their patients. Viral 
load data were only available for a few participants, and was therefore excluded from the analysis. Finally, the findings are 
derived from a sample of men and women residing in one district in one province in South Africa. Thus caution is urged in 




High use of TCAM prior to ART seems to continuously decline over 20 months when on ART. Herbal treatment for 
HIV was associated with non-adherence to ART and should be considered in ART adherence management.  
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